A new perspective on the potential application of RIPK1 in the treatment of sepsis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A new perspective on the potential application of RIPK1 in the treatment of sepsis
Authors
Keywords
-
Journal
Immunotherapy
Volume 15, Issue 1, Pages 43-56
Publisher
Future Medicine Ltd
Online
2023-01-04
DOI
10.2217/imt-2022-0219
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Necroptosis is active and contributes to intestinal injury in a piglet model with lipopolysaccharide challenge
- (2021) Yulan Liu et al. Cell Death & Disease
- Distinct cell death markers identified in critical care patient survivors diagnosed with sepsis
- (2021) Chandra Shekar Mallarpu et al. IMMUNOLOGY LETTERS
- Impact of 1-Hour Bundle Achievement in Septic Shock
- (2021) Byuk Sung Ko et al. Journal of Clinical Medicine
- Association of plasma level of high-mobility group box-1 with necroptosis and sepsis outcomes
- (2021) Hongseok Yoo et al. Scientific Reports
- Targeting RIP Kinases in Chronic Inflammatory Disease
- (2021) Mary Speir et al. Biomolecules
- A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis
- (2021) Kathy Weisel et al. BMJ Open Gastroenterology
- Potent and Selective RIPK1 Inhibitors Targeting Dual‐Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis
- (2021) Xiangbo Yang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study
- (2020) Kristina E Rudd et al. LANCET
- Inhibitors Targeting RIPK1/RIPK3: Old and New Drugs
- (2020) Sofie Martens et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Response to inhibition of receptor‐interacting protein kinase 1 (RIPK1) in active plaque psoriasis: a randomized placebo‐controlled study
- (2020) Kathleen Weisel et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
- (2020) Lauren Mifflin et al. NATURE REVIEWS DRUG DISCOVERY
- Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury
- (2020) Vijay Kumar Frontiers in Immunology
- RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
- (2020) Wei Wang et al. CANCER CELL
- Lysosomal quality control of cell fate: a novel therapeutic target for human diseases
- (2020) Sheng-yu Zhu et al. Cell Death & Disease
- RIPK1 Promotes Energy Sensing by the mTORC1 Pathway
- (2020) Ayaz Najafov et al. MOLECULAR CELL
- RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases
- (2019) Snahel Patel et al. CELL DEATH AND DIFFERENTIATION
- Targeting RIPK1 for the treatment of human diseases
- (2019) Alexei Degterev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation
- (2019) Yves Dondelinger et al. Nature Communications
- Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket group
- (2019) Gregory L. Hamilton et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Sepsis: Inflammation Is a Necessary Evil
- (2019) Christina Nedeva et al. Frontiers in Cell and Developmental Biology
- DNL 104, a Centrally Penetrant RIPK 1 Inhibitor, Inhibits RIP 1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers
- (2019) Hendrika W. Grievink et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- NLRP3 Inflammasome Regulates Development of Systemic Inflammatory Response and Compensatory Anti-Inflammatory Response Syndromes in Mice With Acute Pancreatitis
- (2019) Matthias Sendler et al. GASTROENTEROLOGY
- Chronic inflammation in the etiology of disease across the life span
- (2019) David Furman et al. NATURE MEDICINE
- Necroptosis in development and diseases
- (2018) Bing Shan et al. GENES & DEVELOPMENT
- RIP kinase 1–dependent endothelial necroptosis underlies systemic inflammatory response syndrome
- (2018) Matija Zelic et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of 7-Oxo-2,4,5,7-tetrahydro-6H-pyrazolo[3,4-c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure–Kinetic Relationships
- (2018) Masato Yoshikawa et al. JOURNAL OF MEDICINAL CHEMISTRY
- mTORC1/2 inhibitor and curcumin induce apoptosis through lysosomal membrane permeabilization-mediated autophagy
- (2018) Seung Un Seo et al. ONCOGENE
- Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis
- (2018) Huyan Meng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BiallelicRIPK1mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation
- (2018) Delphine Cuchet-Lourenço et al. SCIENCE
- Inhibition of necroptosis attenuates lung injury and improves survival in neonatal sepsis
- (2018) Alexandra C. Bolognese et al. SURGERY
- Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression
- (2018) Kezhou Zhu et al. Cell Death & Disease
- TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging
- (2018) Daichao Xu et al. CELL
- ABIN-1 heterozygosity sensitizes to innate immune response in both RIPK1-dependent and RIPK1-independent manner
- (2018) Zhenyi Su et al. CELL DEATH AND DIFFERENTIATION
- TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation
- (2018) Elodie Lafont et al. NATURE CELL BIOLOGY
- Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
- (2018) Junying Yuan et al. NATURE REVIEWS NEUROSCIENCE
- Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases
- (2018) Yue Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
- (2017) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Advances in the understanding and treatment of sepsis-induced immunosuppression
- (2017) Fabienne Venet et al. Nature Reviews Nephrology
- RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease
- (2017) Dimitry Ofengeim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytokine storm and sepsis disease pathogenesis
- (2017) Benjamin G. Chousterman et al. Seminars in Immunopathology
- Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis
- (2017) Jiefei Geng et al. Nature Communications
- Necroptosis regulated proteins expression is an early prognostic biomarker in patient with sepsis: a prospective observational study
- (2017) Bing Wang et al. Oncotarget
- RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
- (2016) K Newton et al. CELL DEATH AND DIFFERENTIATION
- RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4
- (2016) Malek Najjar et al. IMMUNITY
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors
- (2016) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
- (2016) Yasushi Ito et al. SCIENCE
- Balance between Hyperinflammation and Immunosuppression in Sepsis
- (2016) Hemang Yadav et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- The Endothelium in Sepsis
- (2016) Can Ince et al. SHOCK
- Holding RIPK1 on the Ubiquitin Leash in TNFR1 Signaling
- (2016) Nieves Peltzer et al. TRENDS IN CELL BIOLOGY
- Activation of Necroptosis in Multiple Sclerosis
- (2015) Dimitry Ofengeim et al. Cell Reports
- RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis
- (2014) James A. Rickard et al. CELL
- Cutting Edge: RIPK1 Kinase Inactive Mice Are Viable and Protected from TNF-Induced Necroptosis In Vivo
- (2014) Apostolos Polykratis et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: RIP1 Kinase Activity Is Dispensable for Normal Development but Is a Key Regulator of Inflammation in SHARPIN-Deficient Mice
- (2014) S. B. Berger et al. JOURNAL OF IMMUNOLOGY
- RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis
- (2014) Nozomi Takahashi et al. NATURE
- Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis
- (2014) K. Newton et al. SCIENCE
- Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death
- (2013) Dimitry Ofengeim et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Structural Basis of RIP1 Inhibition by Necrostatins
- (2013) Tian Xie et al. STRUCTURE
- Formation of the death domain complex between FADD and RIP1 proteins in vitro
- (2012) Young-Hoon Park et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis
- (2012) Jixi Li et al. CELL
- Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase
- (2012) A Degterev et al. CELL DEATH AND DIFFERENTIATION
- Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival
- (2012) Alejo Efeyan et al. NATURE
- A novel role for RIP1 kinase in mediating TNFα production
- (2012) D E Christofferson et al. Cell Death & Disease
- Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis
- (2011) Claudia Günther et al. NATURE
- The Prevalence of TNFα-Induced Necrosis over Apoptosis Is Determined by TAK1-RIP1 Interplay
- (2011) Seda Çöl Arslan et al. PLoS One
- The Dual Functions of Receptor Interacting Protein 1 in Fas-Induced Hepatocyte Death During Sepsis
- (2011) Sam I. McNeal et al. SHOCK
- Autophagy: cellular and molecular mechanisms
- (2010) Danielle Glick et al. JOURNAL OF PATHOLOGY
- Inhibition of NF- B Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes
- (2010) N. Shembade et al. SCIENCE
- NEMO/IKKγ regulates an early NF-κB-independent cell-death checkpoint during TNF signaling
- (2009) D Legarda-Addison et al. CELL DEATH AND DIFFERENTIATION
- The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-κB signalling
- (2009) Noula Shembade et al. EMBO JOURNAL
- Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment
- (2009) Peter Geserick et al. JOURNAL OF CELL BIOLOGY
- Direct activation of protein kinases by unanchored polyubiquitin chains
- (2009) Zong-Ping Xia et al. NATURE
- The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
- (2008) Jingxiang Huang et al. BIOCHEMICAL JOURNAL
- TNF-α Induces Two Distinct Caspase-8 Activation Pathways
- (2008) Lai Wang et al. CELL
- Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
- (2008) G Kroemer et al. CELL DEATH AND DIFFERENTIATION
- cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination
- (2008) Mathieu J.M. Bertrand et al. MOLECULAR CELL
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
- Necroptosis contributes to the NMDA-induced excitotoxicity in rat’s cultured cortical neurons
- (2008) Yanli Li et al. NEUROSCIENCE LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search